Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder
This study has been completed.
Study NCT00235508   Information provided by Sepracor, Inc.
First Received: October 6, 2005   Last Updated: January 8, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Insomnia
Generalized Anxiety Disorder
Additional conditions recognized in this trial
Anxiety Disorders
Disease
Sleep Initiation and Maintenance Disorders
More general conditions related to this trial
Dyssomnias
Mental Disorders
Nervous System Diseases
Pathologic Processes
Sleep Disorders
Sleep Disorders, Intrinsic
Interventions listed in this trial
Eszopiclone (Lunesta)
Sponsors listed in this trial
Sepracor, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services